EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD 15.29 million.

The movement follows the announcement of the quarterly review results for the Hang Seng Index Series on May 22. EDGE MEDICAL-B has been included in the Hang Seng Composite Index. The changes are scheduled to take effect after the market close on June 5, 2026, and will be implemented starting June 8, 2026. Subsequently, the Shanghai and Shenzhen Stock Exchanges are expected to adjust the scope of eligible stocks for the Southbound Stock Connect program accordingly.

EDGE MEDICAL-B is now a potential candidate for inclusion in the Stock Connect scheme, as it meets a series of criteria including market capitalization and liquidity requirements.

The company is pursuing a global expansion strategy and has established a comprehensive product and technology portfolio. This includes multi-port and single-port laparoscopic surgical robots, a remote surgery system, and a bronchoscopy robot. EDGE MEDICAL-B has launched what it claims is the world's only integrated product combining multi-port, single-port, and remote surgical capabilities. The company continues to explore the application value of surgical robots in areas such as precision minimally invasive surgery, telemedicine, and cross-regional medical collaboration.